Supporting this hypothesis, multiple studies have evaluated the benefit of left ventricular assistance devices (LVAD) in insulin sensitivity in HF patients, favoring an improved blood glucose control after LVAD implantation. The gene discussed is INS; the disease is hydrops fetalis.